The effect of neurotensin and secretin on gastric acid secretion and mucosal blood flow in man.
Neurotensin stimulates pancreatic secretion directly and by potentiating the effect of secretin. Neurotensin also inhibits gastric secretion. Secretin inhibits gastric secretion as well, but whether it also interacts with neurotensin is not known. Secretin is known to inhibit gastric mucosal blood flow (GMBF). The effect of neurotensin on GMBF is not known. Acid secretion (triple lumen perfused orogastric tube) and GMBF ([14C]aminopyrine clearance) were therefore measured in 6 subjects during neurotensin, secretin and neurotensin plus secretin infusions. Neurotensin plus secretin reduced acid secretion by a median 130 (range 34-394) mumol/min which was significantly greater than either neurotensin at 36 (7-67) mumol/min or secretin 54 (20-347) mumol/min alone (P less than 0.05). This effect appeared independent of GMBF. Neurotensin plus secretin reduced GMBF by 14 (12-27) ml/min but not significantly more than neurotensin at 11 (3-20) ml/min or secretin 18 (2-27) ml/min alone. Further, there was no correlation between changes in acid output and GMBF during infusion of the peptides. We conclude that the inhibitory effects of neurotensin and secretin on gastric secretion are at least additive and together they may function as an 'enterogastrone'.
D000328:Adult; D000632:Aminopyrine / Q000378:metabolism; D002250:Carbon Radioisotopes; D005744:Gastric Acid / Q000378:metabolism*; D005750:Gastric Juice / Q000187:drug effects; D005753:Gastric Mucosa / Q000098:blood supply*; D006801:Humans; D007700:Kinetics; D008297:Male; D009496:Neurotensin / Q000494:pharmacology*; D012039:Regional Blood Flow / Q000187:drug effects; D012633:Secretin / Q000494:pharmacology*
D002250:Carbon Radioisotopes; D000632:Aminopyrine; D012633:Secretin; D009496:Neurotensin